Gemcitabine with or without docetaxel as second-line therapy in treating patients with metastatic or relapsed, unresectable uterine or soft tissue leiomyosarcoma

• National Cancer Institute

収録刊行物

• http://www.cancer.gov/search/viewclinicaltraials.aspx?cdrid

  http://www.cancer.gov/search/viewclinicaltraials.aspx?cdrid

詳細情報

• CRID: 1572824500454438016
• NII論文ID: 10021237640
• データソース種別:
  • CiNii Articles